Today, 4.5 billion people do not have access to essential health services, which span promotion, prevention, treatment, rehabilitation, and palliative care. Health equity and timely access to innovation, especially for vulnerable populations, is a priority to all actors in the health sector, from companies that innovate to governments that seek to bring health services to...
Read more
Vaccines have long been our greatest defence in public health. As we confront new global challenges, the latest vaccine technology is central to a preventative approach to healthcare. Over the past five decades, vaccines have saved at least 154 million lives, according to the World Health Organization. Diseases like smallpox have been eradicated, and polio...
Read more
2024 has been another incredible year for medical innovation. We have seen new CRISPR technologies made available to patients for the first time, progress in treatments for Alzheimer’s disease, and the roll-out of malaria vaccines to the worst affected countries in the world. These advances – along with so many others – are leading to...
Read more
This compendium of facts and figures aims to provide a snapshot of the contribution of the pharmaceutical industry. Pharmaceutical companies are at the forefront of developing medicines and vaccines that change how we fight and prevent disease and help solve today’s biggest health challenges. In addition to their contribution to healthier societies, pharmaceutical companies also...
Read more
On 19 October 2024, the World Medical Association (WMA) General Assembly unanimously voted to adopt a set of revisions to the Declaration of Helsinki on ethical principles for medical research.
Read moreOn 2 December 2024 in Geneva, IFPMA delivered a statement at the resumed INB 12.
Read moreIFPMA has annouced the appointment of IFPMA’s new CEO Leadership Team.
Read more
On 25 November in Busan, South Korea, IFPMA, GSCF, and IGBA submitted a joint opening statement at the fifth session of the Intergovernmental Negotiating Committee (INC-5) for an international instrument to end plastics pollution.
Read moreJames Anderson, Chair of the AMR Industry Alliance, shares reflections on progress made in the fight against AMR.
Read more
The Biopharmaceutical CEO Roundtable (BCR), which represents the world’s leading biopharmaceutical companies, met in New York City, on 21 November, to discuss global health challenges and public health policies impacting medical innovation. 22 November 2024, New York City – The CEOs of leading biopharmaceutical companies met in New York City to discuss collaborative solutions that...
Read moreThis report from WifOR analyzes the economic impacts of the global pharmaceutical industry, focusing on contributions to Gross Domestic Product (GDP), job creation, and research and development (R&D) activities.
Read more
New data sets out the economic impacts of the global pharmaceutical industry, focusing on contributions to Gross Domestic Product (GDP), job creation, and research and development (R&D) activities.
Read more